Given how tightly held this is, we only really need one institutional investor to like what they see in the August results and that should be sufficient to get this above 50c quite fast. I will be sending the report and presentation around to several fund managers who I know, suggest others do the same as well. A solid operating result, as the company hinted at in the most recent sales update, should really release the lid and let this run hard to fair value.
CMS Proposes Major Increase in Reimbursement for Canaloplasty, page-437
Add EYE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
18.0¢ |
Change
-0.005(2.70%) |
Mkt cap ! $41.23M | |||
| Open | High | Low | Value | Volume |
| 18.5¢ | 18.8¢ | 18.0¢ | $14.78K | 79.92K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 386830 | 18.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.5¢ | 2351 | 1 |
View Market Depth
| Last trade - 16.10pm 17/10/2024 (20 minute delay) ? |
| EYE (ASX) Chart |